This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated UPF2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-UPF2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~147.8 kDa | |
| Observed band | ~170 kDa | |
| Gel | 8–10% | |
| Negative control | siRNA / KO lysate |
| PTM | Phosphorylated | |
| Caveat | Coiled-coil aberrant migration | |
| Regulation | LPS-induced | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for UPF2 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human MCF-7 , Lane 2: human Raji , Lane 3: human THP-1 . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-HUPF2/RENT2/UPF2 antigen affinity purified polyclonal antibody (Catalog # A03627-2) at 0.25 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for HUPF2/RENT2/UPF2 at approximately 170 kDa. The expected band size for HUPF2/RENT2/UPF2 is at 170 kDa |
| Gel % | 8–10% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.25 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 170 kDa |
UPF2 has a 147.8 kDa calculated mass but runs at ~170 kDa on Western blot due to its coiled-coil/repeat structure and phosphorylation, not glycosylation or proteolytic processing.
| predominant band at ~170 kDa in cytoplasmic whole-cell lysate | native full-length UPF2, migrating above its 147.8 kDa calculated mass due to its extended coiled-coil/repeat architecture and phosphorylation |
| single band with no lower satellite bands | only one UPF2 isoform is annotated, so no alternative splice-derived bands are expected |
| band position unchanged between reducing and non-reducing sample prep | UPF2 has no annotated inter-chain disulfide bonds, so it runs as a monomer regardless of reducing agent |
| band present and robust in whole-cell lysate | UPF2 is a cytoplasmic/perinuclear protein rather than a secreted one, so it is retained and detectable in standard whole-cell lysate preps |
| faint band near 148 kDa alongside the dominant ~170 kDa band | may represent the unmodified or less-phosphorylated UPF2 backbone predicted from sequence, present at lower abundance than the mature phosphorylated form |
| predicted mass from UniProt (147.8 kDa, 1272 aa) | sets the calculated baseline, but the native protein runs noticeably higher on SDS-PAGE |
| coiled-coil and repeat domains | large structured regions commonly cause anomalous, slower SDS-PAGE migration, contributing to the shift from 147.8 kDa toward the ~170 kDa observed band |
| phosphothreonine modification at residue 1088 | adds mass and can further retard migration, consistent with a single phosphoprotein species rather than multiple modforms |
| absence of glycosylation sites | rules out glycoform smearing as a cause of the higher apparent size |
| absence of inter-chain disulfide bonds | band position is unaffected by reducing versus non-reducing sample buffer |
| single annotated isoform | no additional splice-variant bands are expected at other molecular weights |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | native UPF2's coiled-coil/repeat structure and phosphorylation slow its SDS-PAGE migration relative to the 147.8 kDa calculated mass | confirm the ~170 kDa band against a known-positive lysate and do not mistake it for nonspecific binding or degradation |
| No band in lysate | incomplete lysis of the cytoplasmic/perinuclear compartment or low UPF2 expression in the cell line used | use a stronger lysis buffer with protease and phosphatase inhibitors and confirm loading with a housekeeping control |
| Multiple bands | the dominant band should be the ~170 kDa mature phosphorylated UPF2, since only one isoform is annotated, so extra lower bands likely reflect degradation | add fresh protease inhibitors, keep lysates cold, and minimize sample handling time before loading |
| Weak or no signal | large proteins above 140 kDa can transfer poorly from the gel to the membrane | extend transfer time or use a lower-percentage/gradient gel and verify transfer efficiency with a total protein stain |
| Fragments below expected size | proteolytic degradation of the large, coiled-coil-rich UPF2 protein during lysate preparation | prepare lysates rapidly on ice with protease inhibitors and avoid repeated freeze-thaw cycles |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for UPF2, answered from its protein features.
BosterBio's UPF2 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-UPF2 antibody delivers top-tier Western blot performance, is extensively cited across published studies, and has been thoroughly validated, including orthogonal cross-validation against negative tissue controls and complementary detection methods, ensuring dependable, specific results for UPF2 detection.
Which to pick: Only one Boster UPF2 antibody is catalogued, A03627-2, which includes an authentic Western blot validation image, making it the clear, single choice for this target; no alternative SKUs are currently listed.